Haematology

Lyophilised plasma – 1 mL provided to assess Dabigatran (Direct Thrombin Inhibitor) measurements

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Dabigatran (Direct Thrombin Inhibitor)

Stabilised whole blood – 5mL provided to assess ESR

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

Option	Compatible Instrument/Method
Option 1	All methods excluding StaRRsed users
Option 2	StaRRsed users ONLY

Lyophilised plasma – 1 mL provided to assess Factor XIII measurements

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Factor XIII (Screen and Assay)

Stabilised whole blood – 1.5 mL provided to assess Full Blood Count parameters.

Frequency / Number of samples

12 surveys / 2 samples per survey

Tests

White Blood Cells

Red Blood Cells

Haemoglobin

Haematocrit

Mean Cell Volume

Mean Cell Haemoglobin

Mean Cell Haemoglobin Concentration

Red Cell Distribution Width – CV

Platelet

Mean Platelet Volume

Lyophilised plasma – 1 mL provided to assess Factor VIII inhibitor detection

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

FVIII Inhibitor

Lyophilised haemolysate – 0.5 mL provided to assess the G6PD screen and assay

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Glucose-6-phosphate dehydrogenase Screen Glucose-6-phosphate dehydrogenase Assay

G6PD Screen G6PD Assay

Stabilised whole blood – ~1.0mL provided to assess the Immunophenotype of patient case studies

Frequency / Number of samples

Haematology Immunophenotyping: 1 sample per survey / 4 surveys

Paroxysmal Nocturnal Haemoglobinuria: 2 samples per survey / 2 surveys

Tests

Haematology Immunophenotyping	Haematology Immunophenotyping – (AML, T and B cell ALL and LPD-Diagnostic Interpretation)
Paroxysmal Nocturnal Haemoglobinuria	PNH Testing

Note: The material assayed is fresh whole blood, which quickly deteriorates under normal transport conditions and should be tested within 3–4 days of dispatch. As such this program is only available to a limited number of destinations outside Australia, New Zealand, Malaysia, Singapore and Hong Kong. Please contact Customer Service at customer.service@rcpaqap.com.au if you are outside these areas. Notification will be sent by email on the day of dispatch.

Lyophilised haemolysate – 1 mL provided to assess Hb A₂, F and Variant and provide a conclusion.

Frequency / Number of samples

4 surveys / 1 sample per survey

Tests

Haemoglobin A2 (Hb A₂)

Haemoglobin F (Hb F)

Variant Haemoglobin (Variant)

Lyophilised plasma – 1 mL provided to assess PT / INR / Fib / APTT / TT

Frequency / Number of samples

8 surveys / 2 samples per survey

Tests

Prothrombin Time (PT)

International Normalised Ratio (INR)

Activated Partial Thromboplastin Time (APTT)

Fibrinogen (Fib)

Thrombin Time (TT)

Lyophilised plasma – 1 mL provided to assess low molecular weight heparin detection

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Low Molecular Weight Heparin monitoring

Note: Participants enrolling in the Heparin Monitoring must enrol in both options if monitoring unfractionated and low molecular weight heparin.

Lyophilised plasma – 2 mL provided to assess all tests relating to Lupus Anticoagulant identification.

Frequency / Number of samples

3 surveys / 2 samples per survey

Tests

Lupus Anticoagulant

Virtual images of peripheral blood to assess the capabilities to describe and identify the malarial parasite species.

Frequency / Number of samples

Malaria Parasite Identification 2 cases per survey / 2 surveys

Malaria Parasite Density Count 1 case per survey / 2 surveys

Tests

Malarial Parasite identification of thin and thick blood films.

Malarial Parasite Density Count